| α‐enolase: a promising therapeutic and diagnostic tumor target M Capello, S Ferri‐Borgogno, P Cappello, F Novelli The FEBS journal 278 (7), 1064-1074, 2011 | 299 | 2011 |
| Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity M Capello, JV Vykoukal, H Katayama, LE Bantis, H Wang, DL Kundnani, ... Nature communications 10 (1), 254, 2019 | 141 | 2019 |
| Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest M Capello, S Ferri-Borgogno, C Riganti, MS Chattaragada, M Principe, ... Oncotarget 7 (5), 5598, 2016 | 129 | 2016 |
| Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis M Principe, S Borgoni, M Cascione, MS Chattaragada, S Ferri-Borgogno, ... Journal of hematology & oncology 10, 1-13, 2017 | 121 | 2017 |
| YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma B Tu, J Yao, S Ferri-Borgogno, J Zhao, S Chen, Q Wang, L Yan, X Zhou, ... JCI insight 4 (21), 2019 | 55 | 2019 |
| Quartz crystal microbalance with dissipation (QCM-D) as tool to exploit antigen–antibody interactions in pancreatic ductal adenocarcinomadetection M Bianco, A Aloisi, V Arima, M Capello, S Ferri-Borgogno, F Novelli, ... Biosensors and bioelectronics 42, 646-652, 2013 | 39 | 2013 |
| Spontaneous tumor regression following COVID-19 vaccination LG de Sousa, DJ McGrail, K Li, ML Marques-Piubelli, C Gonzalez, H Dai, ... Journal for immunotherapy of cancer 10 (3), 2022 | 38 | 2022 |
| Towards pancreatic cancer diagnosis using EIS biochips MS Chiriacò, E Primiceri, AG Monteduro, A Bove, S Leporatti, M Capello, ... Lab on a Chip 13 (4), 730-734, 2013 | 37 | 2013 |
| Spatial transcriptomics depict ligand–receptor cross-talk heterogeneity at the tumor-stroma interface in long-term ovarian cancer survivors S Ferri-Borgogno, Y Zhu, J Sheng, JK Burks, JA Gomez, KK Wong, ... Cancer research 83 (9), 1503-1516, 2023 | 35 | 2023 |
| Endogenous glutamine decrease is associated with pancreatic cancer progression C Roux, C Riganti, SF Borgogno, R Curto, C Curcio, V Catanzaro, ... Oncotarget 8 (56), 95361, 2017 | 35 | 2017 |
| Sio: A spatioimageomics pipeline to identify prognostic biomarkers associated with the ovarian tumor microenvironment Y Zhu, S Ferri-Borgogno, J Sheng, TL Yeung, JK Burks, P Cappello, ... Cancers 13 (8), 1777, 2021 | 24 | 2021 |
| Paradoxical role of AT-rich interactive domain 1A in restraining pancreatic carcinogenesis S Ferri-Borgogno, S Barui, AM McGee, T Griffiths, PK Singh, CG Piett, ... Cancers 12 (9), 2695, 2020 | 20 | 2020 |
| CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop Y Chen, M Capello, MVR Perez, JV Vykoukal, D Roife, Y Kang, ... Molecular metabolism 56, 101426, 2022 | 14 | 2022 |
| CES2 Expression in pancreatic adenocarcinoma is predictive of response to irinotecan and is associated with type 2 diabetes M Capello, JF Fahrmann, MV Rios Perez, JV Vykoukal, E Irajizad, ... JCO Precision Oncology 4, 426-436, 2020 | 14 | 2020 |
| Spatial immunoprofiling of adenoid cystic carcinoma reveals B7-H4 is a therapeutic target for aggressive tumors LG Sousa, DJ McGrail, F Lazar Neto, K Li, ML Marques-Piubelli, ... Clinical Cancer Research 29 (16), 3162-3171, 2023 | 11 | 2023 |
| Targeting dopamine receptor D2 by imipridone suppresses uterine serous cancer malignant phenotype W Hu, L Zhang, S Ferri-Borgogno, SY Kwan, KE Lewis, HT Cun, ... Cancers 12 (9), 2436, 2020 | 11 | 2020 |
| Ryanodine receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes L Zhang, CL Au-Yeung, C Huang, TL Yeung, S Ferri-Borgogno, ... Journal of Experimental & Clinical Cancer Research 41 (1), 242, 2022 | 4 | 2022 |
| Single-cell immune mapping of adenoid cystic carcinoma (ACC) reveals potential therapeutic targets for the aggressive solid subtype. L Guimaraes de Sousa, F Lazar Neto, DJ McGrail, K Li, ... Journal of Clinical Oncology 40 (16_suppl), 6090-6090, 2022 | 3 | 2022 |
| Oncogenic kras requires complete loss of Bap1 function for development of murine intrahepatic cholangiocarcinoma R Marcus, S Ferri-Borgogno, A Hosein, WC Foo, B Ghosh, J Zhao, ... Cancers 13 (22), 5709, 2021 | 3 | 2021 |
| Deep learning on image-omics data in identifying prognostic immune biomarkers for ovarian cancer Y Zhu, S Ferri-Borgogno, J Sheng, TL Yeung, J Burks, P Cappello, ... | 3 | 2020 |
